Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI

Neuropediatrics. 2006 Aug;37(4):209-21. doi: 10.1055/s-2006-924734.

Abstract

Canavan disease is a childhood leukodystrophy caused by mutations in the gene for human aspartoacylase ( ASPA), which leads to an abnormal accumulation of the substrate molecule N-acetyl-aspartate (NAA) in the brain. This study was designed to model the natural history of Canavan disease using MRI and proton magnetic resonance spectroscopy ( (1)H-MRS). NAA and various indices of brain structure (morphology, quantitative T1, fractional anisotropy, apparent diffusion coefficient) were measured in white and gray matter regions during the progression of Canavan disease. A mixed-effects statistical model was used to fit all outcome measures. Longitudinal data from 28 Canavan patients were directly compared in each brain region with reference data obtained from normal, age-matched pediatric subjects. The resultant model can be used to non-invasively monitor the natural history of Canavan disease or related leukodystrophies in future studies involving drug, gene therapy, or stem cell treatments.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / metabolism
  • Atrophy
  • Brain / pathology*
  • Canavan Disease / diagnosis*
  • Case-Control Studies
  • Child, Preschool
  • Confidence Intervals
  • Diffusion Magnetic Resonance Imaging / methods*
  • Dipeptides / metabolism
  • Female
  • Humans
  • Infant
  • Magnetic Resonance Spectroscopy / methods*
  • Male
  • Protons*
  • Reference Values

Substances

  • Dipeptides
  • Protons
  • isospaglumic acid
  • Aspartic Acid
  • N-acetylaspartate